B+
Bull case
25%
Probability
Target price
$100.00
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
RDNT
RadNetDNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$78.00
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$50.00
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-10-02
Recent news sentiment (30D)
-26.0
Negative
Company
-
Unavailable
Macro
-26.0
Negative
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+65.4
Score
AI commentary
The official second-quarter release supports a positive operating-news tone, but the packet does not establish the earnings-day price reaction or subsequent analyst revisions. The $67.70 October 1 anchor is below the prior baseline's $71.31 September 24 anchor; no cause is established. Social, options, short-interest and employee measures are unavailable, so their zero fields are not neutral readings. The supplied August 10 10-Q note confirms filing context but contains no usable operating detail. [#10-Q-2026-08-10]
RankAlpha Sentiment Codex - 2026-10-02
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-12-31eventDelivery against raised 2026 Imaging Center guidanceMedium impact
RadNet reported second-quarter revenue of $622.7 million and adjusted EBITDA of $99.7 million, raised its 2026 Imaging Center revenue, adjusted EBITDA and free-cash-flow guidance, and reaffirmed Digital Health guidance. Full-year delivery is the principal near-term test. [#SEC-8K-2026-08-10]
2026-12-31eventBreast-ultrasound AI rolloutMedium impact
Management said DeepHealth's breast-ultrasound AI solution received FDA clearance in late July and that RadNet expects to deploy it across its breast-imaging centers by year-end. Deployment and any realized revenue or cost savings remain to be verified. [#SEC-8K-2026-08-10]
2027-06-30catalystAdvanced-imaging volume and mixHigh impact
Second-quarter aggregate advanced-imaging procedures grew 21.2%, same-center volume grew 9.6%, and advanced imaging reached 29.9% of procedures versus 27.5% a year earlier. Sustaining that mix and its margin contribution is the longer-term test. [#SEC-8K-2026-08-10]
Recommendation
N/A
No formal recommendation provided.
As of 2026-10-02 • Updated nightlySource: Internal modelMethodology